Methods
In our single-center retrospective study, we identified 75 patients who underwent high-risk PCI with hemodynamic support from March 2007 to January 2010. The number of patients per group was as follows: IABP=48, TH=12 and IMP=15. The primary endpoint was major in-hospital adverse cardiac events (MACE), consisting of reinfarction, repeat revascularization and death. The secondary endpoint was in-hospital vascular complications defined as need for transfusion, vascular repair or CVA.
Methods
In our single-center retrospective study, we identified 75 patients who underwent high-risk PCI with hemodynamic support from March 2007 to January 2010. The number of patients per group was as follows: IABP=48, TH=12 and IMP=15. The primary endpoint was major in-hospital adverse cardiac events (MACE), consisting of reinfarction, repeat revascularization and death. The secondary endpoint was in-hospital vascular complications defined as need for transfusion, vascular repair or CVA.